115 related articles for article (PubMed ID: 27845894)
1. Overexpression of ATPase Na+/+ transporting alpha 1 polypeptide, ATP1A1, correlates with clinical diagnosis and progression of esophageal squamous cell carcinoma.
Wu IC; Chen YK; Wu CC; Cheng YJ; Chen WC; Ko HJ; Liu YP; Chai CY; Lin HS; Wu DC; Wu MT
Oncotarget; 2016 Dec; 7(51):85244-85258. PubMed ID: 27845894
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
3. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
Hu YC; Lam KY; Law S; Wong J; Srivastava G
Clin Cancer Res; 2001 Nov; 7(11):3519-25. PubMed ID: 11705871
[TBL] [Abstract][Full Text] [Related]
4. A cancer-array approach elucidates the immune escape mechanism and defects in the DNA repair system in esophageal squamous cell carcinoma.
Dadkhah E; Naseh H; Farshchian M; Memar B; Sankian M; Bagheri R; Forghanifard MM; Montazer M; Kazemi Noughabi M; Hashemi M; Abbaszadegan MR
Arch Iran Med; 2013 Aug; 16(8):463-70. PubMed ID: 23906251
[TBL] [Abstract][Full Text] [Related]
5. The overexpression of DBC1 in esophageal squamous cell carcinoma correlates with poor prognosis.
Kim SH; Kim JH; Yu EJ; Lee KW; Park CK
Histol Histopathol; 2012 Jan; 27(1):49-58. PubMed ID: 22127596
[TBL] [Abstract][Full Text] [Related]
6. Na+/K+-ATPase α1 subunit, a novel therapeutic target for hepatocellular carcinoma.
Zhuang L; Xu L; Wang P; Jiang Y; Yong P; Zhang C; Zhang H; Meng Z; Yang P
Oncotarget; 2015 Sep; 6(29):28183-93. PubMed ID: 26334094
[TBL] [Abstract][Full Text] [Related]
7. Intensive expression of UNC-51-like kinase 1 is a novel biomarker of poor prognosis in patients with esophageal squamous cell carcinoma.
Jiang S; Li Y; Zhu YH; Wu XQ; Tang J; Li Z; Feng GK; Deng R; Li DD; Luo RZ; Zhang MF; Qin W; Wang X; Jia WH; Zhu XF
Cancer Sci; 2011 Aug; 102(8):1568-75. PubMed ID: 21518141
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
[TBL] [Abstract][Full Text] [Related]
9. Gankyrin oncoprotein overexpression as a critical factor for tumor growth in human esophageal squamous cell carcinoma and its clinical significance.
Ortiz CM; Ito T; Tanaka E; Tsunoda S; Nagayama S; Sakai Y; Higashitsuji H; Fujita J; Shimada Y
Int J Cancer; 2008 Jan; 122(2):325-32. PubMed ID: 17935131
[TBL] [Abstract][Full Text] [Related]
10. MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2.
Shao Y; Li P; Zhu ST; Yue JP; Ji XJ; Ma D; Wang L; Wang YJ; Zong Y; Wu YD; Zhang ST
Oncotarget; 2016 Mar; 7(12):15173-86. PubMed ID: 26959737
[TBL] [Abstract][Full Text] [Related]
11. Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC.
Hu YC; Lam KY; Law S; Wong J; Srivastava G
Clin Cancer Res; 2001 Aug; 7(8):2213-21. PubMed ID: 11489794
[TBL] [Abstract][Full Text] [Related]
12. Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma.
Xue LY; Hu N; Song YM; Zou SM; Shou JZ; Qian LX; Ren LQ; Lin DM; Tong T; He ZG; Zhan QM; Taylor PR; Lu N
BMC Cancer; 2006 Dec; 6():296. PubMed ID: 17187659
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
Guo YL; Shan BE; Guo W; Dong ZM; Zhou Z; Shen SP; Guo X; Liang J; Kuang G
J Biomed Sci; 2017 Jan; 24(1):6. PubMed ID: 28077137
[TBL] [Abstract][Full Text] [Related]
14. Cortactin overexpression in the esophageal squamous cell carcinoma and its involvement in the carcinogenesis.
Hsu NY; Yeh KT; Chiang IP; Pai LY; Chen CY; Ho HC
Dis Esophagus; 2008; 21(5):402-8. PubMed ID: 19125793
[TBL] [Abstract][Full Text] [Related]
15. RANK overexpression as a novel esophageal cancer marker: validated immunohistochemical analysis of two different ethnicities.
Cui X; Peng H; Jin J; Li T; Zhang S; Jin T; Li S; Liu C; Liang W; Li F; Chen Y
Int J Clin Exp Pathol; 2015; 8(2):2249-58. PubMed ID: 25973136
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of microRNA-100 in esophageal squamous cell carcinoma.
Zhou S; Yang B; Zhao Y; Xu S; Zhang H; Li Z
J Surg Res; 2014 Dec; 192(2):515-20. PubMed ID: 25218280
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the circulating level of fibroblast activation protein α for diagnosis of esophageal squamous cell carcinoma.
Liao Y; Xing S; Xu B; Liu W; Zhang G
Oncotarget; 2017 May; 8(18):30050-30062. PubMed ID: 28415791
[TBL] [Abstract][Full Text] [Related]
18. ANO1 protein as a potential biomarker for esophageal cancer prognosis and precancerous lesion development prediction.
Shang L; Hao JJ; Zhao XK; He JZ; Shi ZZ; Liu HJ; Wu LF; Jiang YY; Shi F; Yang H; Zhang Y; Liu YZ; Zhang TT; Xu X; Cai Y; Jia XM; Li M; Zhan QM; Li EM; Wang LD; Wei WQ; Wang MR
Oncotarget; 2016 Apr; 7(17):24374-82. PubMed ID: 27016410
[TBL] [Abstract][Full Text] [Related]
19. [Expression of Fas, Fas ligand, Fas-associated death domain protein, caspase 8 and mutant P53 protein in esophageal squamous cell carcinoma].
Xue LY; Ren LQ; Luo W; Guan XJ; Zou SM; Zheng S; Bi R; Xie YQ; He ZG; Lü N
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):150-4. PubMed ID: 17425843
[TBL] [Abstract][Full Text] [Related]
20. Transforming capacity of two novel genes JS-1 and JS-2 located in chromosome 5p and their overexpression in human esophageal squamous cell carcinoma.
Fatima S; Chui CH; Tang WK; Hui KS; Au HW; Li WY; Wong MM; Cheung F; Tsao SW; Lam KY; Beh PS; Wong J; Law S; Srivastava G; Ho KP; Chan AS; Tang JC
Int J Mol Med; 2006 Jan; 17(1):159-70. PubMed ID: 16328025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]